{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:48:36Z","timestamp":1791229716994,"version":"4.1.0"},"reference-count":0,"publisher":"Wiley","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1067\/mcp.2000.104736","type":"journal-article","created":{"date-parts":[[2003,11,13]],"date-time":"2003-11-13T07:16:51Z","timestamp":1068707811000},"page":"275-282","source":"Crossref","is-referenced-by-count":294,"title":["Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation"],"prefix":"10.1111","volume":"67","author":[{"given":"P","family":"MANYIKE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"KHARASCH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"KALHORN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"SLATTERY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","container-title":["Clinical Pharmacology & Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T08:14:55Z","timestamp":1699344895000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1067\/mcp.2000.104736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["S0009923600563942"],"URL":"https:\/\/doi.org\/10.1067\/mcp.2000.104736","relation":{},"ISSN":["0009-9236"],"issn-type":[{"value":"0009-9236","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}